Eskenazi Hospital
Indianapolis, Indiana, 46202, United States
NCT Number: NCT03095443
DDM is a study designed to Test the efficacy of personalized music therapy in reducing delirium incidence and severity among patients admitted to the Intensive Care Unit.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Indianapolis, Indiana, 46202, United States
Over 1 million adults are admitted to the intensive care unit and placed on mechanical ventilation on an annual basis. Intravenous sedatives and analgesics are commonly administered to these patients to reduce pain and anxiety. While the recent reduction in benzodiazepine usage has helped reduced ICU-related acute brain dysfunction (delirium), up to 80% of ventilated patients still develop acute brain failure. This is characterized by disturbance of consciousness with reduced ability to focus, sustain or shift attention, occurring over a short period of time and fluctuating over the course of a day.
Acute brain dysfunction has both short-term and long-term health impacts. It is associated with increased hospital length of stay, increased in-hospital mortality and post-discharge mortality as well increased health-care costs. Patients who experience delirium are at greater risk for post-discharge institutionalization and newly acquired cognitive impairment similar to dementia.
Despite the prevalence and morbidity associated with delirium, there is a scarcity of effective pharmacological and non-pharmacological interventions to prevent and treat this condition. While music therapy has shown to reduce anxiety and stress in cancer and dementia patients, these studies were performed outside the intensive care unit. It is hypothesized that music lowers inflammatory mediators such as cytokines and cortisol. Delirium pathophysiology similar to anxiety has a strong inflammatory component with excess of pro-inflammatory cytokines such as interleukins 1, 6, and 8. Given the beneficial effects of music in reducing inflammatory mediators, it stands to reason that such intervention will have a beneficial impact on reducing delirium.
The investigators propose a randomized, three-group (personalized music intervention versus generic music intervention versus attention control) trial to test the feasibility and efficacy of music therapy in reducing delirium incidence, duration, and severity among critically ill patients in the ICU.
Our study focuses on the effect of music therapy on the incidence and severity of delirium in the intensive care unit at a large urban academic health center.
The investigators hypothesize that music therapy will lead to reduced levels of anxiety, delirium and need for sedating medications, leading to shorter hospital stays.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participant receives personalized playlist.
Participant receives a standard low beats per minute playlist.
Participant receives an audio-book.
Time frame: Date of study enrollment through discharge from ICU, or date of study enrollment up to 28 days
the number of participants approached and their rates of consent
Time frame: Date of study enrollment through discharge from ICU, or date of study enrollment up to 28 days
number of listening sessions completed per patient
Time frame: Date of study enrollment through discharge from ICU, or date of study enrollment up to 28 days
Number of patients who complete the study.
Time frame: Date of study enrollment through discharge from ICU, or date of study enrollment up to 28 days
Patient-preferred music association with reducing delirium incidence as measured by CAM-ICU.
Indiana University
Other
Acronym: DDM
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07536854
Brain Dysfunction, Confusion
Suwon, Kyonggi-do, South Korea
View Trial DetailsNCT04742673
Cognition Disorders, Cognitive Dysfunction
Nashville, Tennessee, United States
View Trial DetailsNCT06019078
Agnosia, Analgesia
Abbotsford British Columbia, British Columbia, Canada
View Trial DetailsNCT07296029
Confusion, Critical Illness
Kingston, Ontario, Canada
View Trial Details